Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-001081
Filing Date
2025-01-08
Accepted
2025-01-08 14:08:47
Documents
1
Period of Report
2025-01-08

Document Format Files

Seq Description Document Type Size
1 form4-01082025_070143.html 4  
1 form4-01082025_070143.xml 4 23166
  Complete submission text file 0001415889-25-001081.txt   24665
Mailing Address C/O MIRATI THERAPEUTICS INC. 9393 TOWN CENTRE DRIVE, STE 200 SAN DIEGO CA 92121
Business Address
Gergen Mark J (Reporting) CIK: 0001373110 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39376 | Film No.: 25517880

Mailing Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-779-3100
Poseida Therapeutics, Inc. (Issuer) CIK: 0001661460 (see all company filings)

IRS No.: 472846548 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)